Healthcare >> Sector Roundtables >> August 14, 2000
YI RI, MD, PhD, is a Team Member at Mehta Partners LLC. He earned a
combined advanced degree in Neuroscience from the Albert Einstein
College of Medicine, New York, and has since worked as a science advisor
evaluating patent portfolio, clinical trial studies and patent
infringement issues. Profile
VIREN MEHTA, Pharm.D, is a Managing Member of Mehta Partners LLC. He has
over 25 years of experience in the pharmaceutical and biotechnology
industry, investment research, strategic advisory services, and asset
management. Prior to founding Mehta and Isaly, where he pioneered an in-
depth valuation methodology for biotechnology companies, Dr. Mehta was a
part of the strategic planning team of the international division at
Merck & Co. He earned a Doctor of Pharmacy from the University of
Southern California, and an MBA from the Anderson School of Business at
the University of California, Los Angeles. Profile
THOMAS DESCHAMPS is a Team Member at Mehta Partners LLC. He holds a
Bachelor of Science degree in Cell Biology and worked in biomedical
sales, providing consulting to the scientific research community. Mr.
DesChamps is completing an MBA from the Stern School of Business at New
York University. Profile
SUSHANT KUMAR, PhD, is a Team Member at Mehta Partners LLC. He has an
extensive background in cancer research and has published numerous
scientific articles. He was an American Cancer Society postdoctoral
fellow at Harvard Medical School, where he conducted research in viral
oncology. Dr. Kumar holds a Doctorate in Molecular Biology from UMDNJ '
Center for Advanced Biotechnology and Medicine. Prior to joining the
firm, he was a senior technology analyst and consultant at Genesis Group
Associates, where he covered a wide range of technology assessment and
market research activities. Profile
NAVDEEP S. JAIKARIA joined Rodman & Renshaw, Inc., as a Senior
Biotechnology Analyst in July 2003. Previously, Dr. Jaikaria was a
Senior Biotechnology Analyst covering small and mid-cap biotechnology
companies at Leerink Swann & Company as well as Mehta Partners. Dr.
Jaikaria obtained his PhD at New York Medical College in Cell Biology
and Anatomy and conducted postdoctoral research at The Rockefeller
University. His scientific research focused on infectious diseases and
cancer. Before joining Wall Street, Dr. Jaikaria also served as a
consultant to biotechnology and pharmaceutical companies. Profile
MARK W. RAVERA, PhD, is a Team Member at Mehta Partners LLC. He has
industry science experience (Aventis/RPR, Novartis/Sandoz, Schering
Plough Research Institute) and global marketing exposure from Bristol-
Myers Squibb and prior, was a Senior Scientist at DGI Biotechnologies,
specializing in phage display technologies. His PhD (George Washington
University) is in Genetics and his MBA was earned at Rutgers University. Profile
AJAY BANSAL is a Team Member at Mehta Partners. A seasoned industry
manager, he most recently worked with Arthur D. Little's pharmaceutical
consulting group and, prior to that, at Novartis, US and Switzerland.
Mr. Bansal served as Executive Director, Strategy and Special Projects,
in Ciba-Geigy's pharma division and holds Master's of Science degrees in
Management from Kellogg Graduate School of Management and in Engineering
and Operations Research from Northwestern University. He was a
significant participant in the Ciba-Chiron partnership and has extensive
consulting experience with Arthur D. Little and McKinsey & Company. Mr.
Bansal is proficient in German. Profile
investing in health care?
Mr. Mehta: Mehta Partners is dedicated to identifying the best
investment ideas anywhere in the
